PharmStockPharmacy Stock

Latisse Ophthalmic Solution
Latisse Ophthalmic Solution

58.17
For patients managing eye conditions, this generic medicine modulates hair follicle growth cycles to support lash volume and density.
Ingredient
Bimatoprost
Category
Eye Care
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Bimatoprost
Reference Brand
Bimatoprost
Product Origin
Generic Brand
Product Manufacturer
Allergan
Product Form
Ophthalmic Solution
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Topical Ophthalmic Agent
Pharmacological Class
Prostaglandin Analog
Clinical Indications
Eyelash hypotrichosis
Manufacturer Description
Intended to relieve eyelash sparsity to support lash thickness and target aesthetic follicle growth.
Mechanism of Action
Stimulates the anagen (growth) phase of eyelash follicles, prolonging follicle activation to increase lash length and density.
Route of Administration
Ophthalmic
Onset Time
4–8 weeks
Contraindications
Hypersensitivity to bimatoprost
Severe Adverse Events
Macular edema — requires immediate medical attention
Common Side Effects
Conjunctival hyperemia, Eye pruritus, Dry eyes
Uncommon Side Effects
Eyelash growth, Skin hyperpigmentation, Iris pigmentation change
Pregnancy Safety Warnings
TGA Category C: Minimal absorption. Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Bimat
Information related to Latisse Ophthalmic Solution is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access OCP Medication Online - Diane-35 Australia